Supply Chain Intelligence

ProQR Therapeutics N.V. Supply Chain

PRQR supply chain intelligence for ProQR Therapeutics N.V.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PRQR ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
3Customers
1Debt Items
20Related Chains

ProQR Therapeutics N.V. Suppliers

TickerNameConfidenceEvidence
LLY Eli Lilly and Company 72% — ​ ( ) The effect of changes in foreign exchange rates ​ — ​ — ​ — Other changes ​ ​ ​ ​ ​ ​ Interest expense ​ ​ — ​ — Interest paid ​ — ​ — ​ — Effect of waived loan agreements ​ — ​ — ​ — Effect …
LLY Eli Lilly and Company 72% Reciprocal relationship from LLY graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from LLY graph: Reciprocal relationship from PRQR graph: — ​ ( ) The effect of changes in fore…
MIRM Mirum Pharmaceuticals, Inc. 72% Reciprocal relationship from MIRM graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from MIRM graph: Reciprocal relationship from PRQR graph: Reciprocal relationship from MIRM g…

ProQR Therapeutics N.V. Customers

TickerNameConfidenceEvidence
LLY Eli Lilly and Company 85% — ​ ( ) The effect of changes in foreign exchange rates ​ — ​ — ​ — Other changes ​ ​ ​ ​ ​ ​ Interest expense ​ ​ — ​ — Interest paid ​ — ​ — ​ — Effect of waived loan agreements ​ — ​ — ​ — Effect …
LLY Eli Lilly and Company 85% Reciprocal relationship from LLY graph: Reciprocal relationship from PRQR graph: — ​ ( ) The effect of changes in foreign exchange rates ​ — ​ — ​ — Other changes ​ ​ ​ ​ ​ ​ Interest expense ​ ​ — ​…
MIRM Mirum Pharmaceuticals, Inc. 72% Reciprocal relationship from MIRM graph: future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced dem…

ProQR Therapeutics N.V. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRQR-DEBT Debt stack $18.3M 90% Market cache reports total debt of $18.3M.

ProQR Therapeutics N.V. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ProQR Therapeutics N.V..

ProQR Therapeutics N.V. Ownership

HolderNameConfidenceEvidence
PRQR-OWNER-ADAGE-CAPITAL-PARTNERS-GP-L-L-C ADAGE CAPITAL PARTNERS GP, L.L.C. 90% 13F overlay lists ADAGE CAPITAL PARTNERS GP, L.L.C. as top holder; 70 tracked holders.

ProQR Therapeutics N.V. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ACIU AC Immune SA 100.00 2
ARWR Arrowhead Pharmaceuticals, Inc. 100.00 2
BYSI BeyondSpring Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ACRS Aclaris Therapeutics, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
BCYC Bicycle Therapeutics plc 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
CMMB Chemomab Therapeutics Ltd. 100.00 2
VNDA Vanda Pharmaceuticals Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
View PRQR supply chain intel →

Explore the full interactive supply chain map for ProQR Therapeutics N.V..

Open PRQR supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map